Deutsche Bank’s IGM Biosciences IGMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-7,520
| Closed | -$8.42K | – | 3661 |
|
|
2025
Q2 | $8.42K | Sell |
7,520
-39,253
| -84% | -$48K | ﹤0.01% | 3511 |
|
|
2025
Q1 | $53.8K | Buy |
46,773
+35,546
| +317% | +$66.1K | ﹤0.01% | 3364 |
|
|
2024
Q4 | $68.6K | Buy |
11,227
+24
| +0.2% | +$285 | ﹤0.01% | 3369 |
|
|
2024
Q3 | $185K | Buy |
11,203
+354
| +3% | +$3.88K | ﹤0.01% | 2959 |
|
|
2024
Q2 | $74.5K | Buy |
10,849
+5,302
| +96% | +$45.4K | ﹤0.01% | 3215 |
|
|
2024
Q1 | $53.5K | Sell |
5,547
-6,155
| -53% | -$71.3K | ﹤0.01% | 3376 |
|
|
2023
Q4 | $97.2K | Buy |
+11,702
| New | +$68K | ﹤0.01% | 3230 |
|
|
2023
Q3 | – | Sell |
-4,965
| Closed | -$45.8K | – | 3760 |
|
|
2023
Q2 | $45.8K | Sell |
4,965
-2,158
| -30% | -$24.2K | ﹤0.01% | 3487 |
|
|
2023
Q1 | $97.9K | Buy |
7,123
+1,795
| +34% | +$37.1K | ﹤0.01% | 3335 |
|
|
2022
Q4 | $90.6K | Sell |
5,328
-4,434
| -45% | -$88.7K | ﹤0.01% | 3373 |
|
|
2022
Q3 | $222K | Buy |
9,762
+3,840
| +65% | +$77.5K | ﹤0.01% | 2888 |
|
|
2022
Q2 | $107K | Buy |
5,922
+1,180
| +25% | +$21K | ﹤0.01% | 3493 |
|
|
2022
Q1 | $127K | Sell |
4,742
-487
| -9% | -$9.07K | ﹤0.01% | 3491 |
|
|
2021
Q4 | $154K | Buy |
5,229
+260
| +5% | +$12.9K | ﹤0.01% | 3503 |
|
|
2021
Q3 | $327K | Sell |
4,969
-160
| -3% | -$12.2K | ﹤0.01% | 3299 |
|
|
2021
Q2 | $426K | Buy |
5,129
+256
| +5% | +$19K | ﹤0.01% | 3324 |
|
|
2021
Q1 | $373K | Sell |
4,873
-4,221
| -46% | -$384K | ﹤0.01% | 3285 |
|
|
2020
Q4 | $803K | Buy |
9,094
+5,162
| +131% | +$363K | ﹤0.01% | 2596 |
|
|
2020
Q3 | $290K | Sell |
3,932
-245
| -6% | -$14.5K | ﹤0.01% | 2985 |
|
|
2020
Q2 | $304K | Buy |
4,177
+2,421
| +138% | +$147K | ﹤0.01% | 2894 |
|
|
2020
Q1 | $98K | Sell |
1,756
-74
| -4% | -$3.24K | ﹤0.01% | 3260 |
|
|
2019
Q4 | $69K | Buy |
+1,830
| New | +$46K | ﹤0.01% | 3772 |
|
Other funds holding IGMS
Deutsche Bank's IGMS Position: Q3 2025 in Review
Deutsche Bank sold out of IGM Biosciences (IGMS) in Q3 2025, closing a stake of 7,520 shares — an estimated $8.42K sold.
Deutsche Bank first reported a position in IGMS in Q4 2019 and held it in 22 quarters. The position peaked at $803K in Q4 2020. 1 fund tracked by Wall St. Rank holds IGMS as of Q3 2025.
- Deutsche Bank reported no remaining IGM Biosciences position as of Q3 2025 after selling out during the quarter.
- Deutsche Bank sold 7,520 IGM Biosciences shares in Q3 2025, an estimated $8.42K.
- Deutsche Bank first reported a position in IGM Biosciences in Q4 2019 and held it in 22 quarters.
- Deutsche Bank's IGM Biosciences position peaked at $803K in Q4 2020.
- 1 fund tracked by Wall St. Rank held IGM Biosciences as of Q3 2025.
Based on Deutsche Bank's 13F filing for Q3 2025, filed 13 Nov 2025.